QTQue Chi Truong-Bolduc

Que Chi Truong-Bolduc

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Que Chi Truong-Bolduc has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efflux reprogramming promotes Staphylococcus aureus persistence with Pseudomonas aeruginosa in cystic fibrosis

    by Q. C. Truong-Bolduc, Y. Wang, B. Alvarez-Carcamo, C. Steifman, B. G. Lawton, L. M. Yonker, B. P. Hurley, L. G. Rahme, D. C. Hooper

    Staphylococcus aureus persists in cystic fibrosis (CF) airways despite in vitro antibiotic susceptibility, suggesting that efflux reprogramming driven by environmental and polymicrobial interactions with Pseudomonas aeruginosa promotes survival in this setting. In this study, we investigated how CF-like conditions and co-infection with P. aeruginosa influence S. aureus physiology and antimicrobial response. Using artificial sputum medium (ASM) and co-culture models, we found that ASM induced a selective transcriptional response characterized by upregulation of the multidrug efflux pump tet38 , while other pumps remained minimally expressed. In the presence of P. aeruginosa , S. aureus maintained tet38 expression but additionally induced norB , indicating a redistribution of efflux activity under polymicrobial stress. P. aeruginosa metabolites, including quinolines and phenazines, contributed to this response, and deletion of tet38 or norB significantly reduced S. aureus fitness in ASM and co-culture conditions. Analysis of S. aureus clinical isolates from people with CF revealed a similar hierarchy, with Tet38 and NorB as the predominant efflux pumps, particularly in S. aureus isolates co-recovered with P. aeruginosa . Despite exhibiting only low-level increases in MICs, these isolates demonstrated enhanced survival in ASM. Notably, S. aureus isolates paired with clinical P. aeruginosa strains showed improved survival compared with survival when paired with a P. aeruginosa reference strain, consistent with adaptation toward coexistence. Together, these findings demonstrate that CF-like environmental conditions and polymicrobial interactions drive selective reprogramming of efflux pumps that promote S. aureus persistence without conferring high-level resistance, highlighting a mechanism of antibiotic tolerance not captured by standard susceptibility testing.

  • Open Access

    ABC and MFS efflux transporters mediate antibiotic resistance and bile salt tolerance in Enterococcus faecalis

    by Q. C. Truong-Bolduc, Y. Wang, S. S. Mello, M. C. Phillips, M. S. Gilmore, D. C. Hooper

    Bacteria that reside in the gastrointestinal tract must adapt to the antibacterial properties of bile salts (BSs) and other compounds. We investigated five putative transporters of the enteric-colonizing Enterococcus faecalis for their roles in adaptation to BS and antibiotic resistance. Transcript levels of ef2593 and ef0575 increased over fivefold, and ef0420 increased 12-fold when exposed to 0.02% and 0.1% BS concentrations. No change in the expression of ef2592 or e f1814 was seen. E. faecalis wild-type MMH594 overexpressing efflux pumps by plasmid constructs (EF2592, EF2593, EF0575, EF0420) or by a pre-exposure to 0.02% BS (EF2593 or EF0420) showed a higher CFU/mL than wild type alone when exposed to 0.3% BS, indicating adaptation of E. faecalis to resist a higher BS level in the medium, and that E. faecalis BS response involved multiple transporters. In MIC assays, the following overexpressors also showed a twofold increase in antibiotic resistance: EF2592 and EF2593 (daptomycin, vancomycin); EF0420 (daptomycin, oritavancin); and EF1814 (daptomycin, levofloxacin, oritavancin, and vancomycin). While no change in EF0575-overexpressor, mutant 0575 showed a significant increase in susceptibility to daptomycin, linezolid, levofloxacin, and oritavancin. In addition, nisin-induced overexpression of several transporters from a plasmid in Lactococcus lactis also increased the MICs of multiple antibiotics, most notably for EF1814, with a 4- to 16-fold increase in the MICs of daptomycin, levofloxacin, linezolid, and vancomycin. These data indicate that expression of multiple E. faecalis transporters responds to bile salts and may contribute to survival and colonization in the gut, as well as causing low-level multidrug resistance. Bile salts are key antimicrobial components of the gastrointestinal tract, and bacterial adaptation to bile salt stress is critical for host colonization and persistence. In this study, we demonstrate that multiple E. faecalis transporters are induced by bile salts and contribute to adaptation at physiologically relevant bile salt concentrations. Importantly, several of these transporters also confer low-level resistance to clinically important antibiotics, including daptomycin, vancomycin, levofloxacin, linezolid, and oritavancin. These findings suggest that transport systems selected for survival in the intestinal environment may have the unintended consequence of increasing antibiotic tolerance and multidrug resistance. By linking host-associated environmental stress with antimicrobial resistance phenotypes, this work advances our understanding of how gut colonization factors can influence bacterial persistence and therapeutic outcomes. The identified transporters represent potential targets for strategies to limit both intestinal colonization and antibiotic resistance in E. faecalis .

  • Open Access

    NorA and Tet38 efflux pumps enable Staphylococcus aureus survival in the cystic fibrosis airway environment, resistance to antibiotics, and coinfection with Pseudomonas aeruginosa

    by Q. C. Truong-Bolduc, Y. Wang, B. G. Lawton, J. J. Zweifach, G. M. McDevitt, Y. El Abdellaoui, H. Brown Harding, L. M. Yonker, L. G. Rahme, J. M. Vyas, et al.

    Efflux pumps play multiple roles in bacterial physiology, environmental adaptation, and antibiotic resistance. Early cystic fibrosis (CF) airway infections start with Staphylococcus aureus ( SA ), often later followed by Pseudomonas aeruginosa ( PA ) infections. In this study, we have evaluated the role of SA pumps NorA and Tet38 in survival and interaction with PA in CF patients. Data showed a ≥4-log 10 CFU/mL growth deficit of SA mutants ΔnorA and Δtet38 in an artificial sputum medium (ASM), suggesting NorA and Tet38 contributed to SA growth in CF sputum. In ASM, mucin activated norA but inhibited tet38, while extracellular DNA activated tet38 but inhibited norA , demonstrating complementary roles of mucin and DNA in affecting NorA and Tet38 expression. Furthermore, exposure of SA wild type to PA -excreted molecules affected pump expression; 3,4-dihydroxy-2-heptylquinoline PQS caused an increase in tet38 but a decrease in norA , 4-hydroxy-2-heptylquinoline HHQ caused a decrease in norA and tet38 , and pyocyanin PYO caused a modest increase in norA , demonstrating differing additional roles of PA -secreted molecules influencing NorA and Tet38 expression. Evaluation of 48 randomly selected unique CF-associated SA showed that 18.8% were NorA-overexpressors and 10.4% were Tet38-overexpressors. NorA-overexpressors showed a fourfold increase in pyocyanin MIC and ≥16-fold in ciprofloxacin MIC. Furthermore, 89% of NorA-overexpressors carried an insertion of CAAT/ACAA/CTAT at the (−10) motif of the norA promoter, and 62.5% of these were co-isolated with PA . These data showed that SA survives PA killing in CF sputum conditions using sputum key components and PA -specific signal molecules to regulate NorA and Tet38 expression.


  • Open Access

    Enhanced Quinolone Resistance and Differential Expression of Efflux Pump nor Genes in Staphylococcus aureus Grown in Platelet Concentrates

    by Carina Paredes, Que Chi Truong-Bolduc, Yin Wang, David C. Hooper, Sandra Ramirez-Arcos

    Background/Objective: Platelet concentrates (PCs) are used in transfusion medicine to treat bleeding disorders. Staphylococcus aureus, a predominant PC contaminant, has been implicated in several adverse transfusion reactions. The aim of this study was to investigate the impact of PC storage on S. aureus resistance to quinolones, which are commonly used to treat S. aureus infections. Methods/Results: Four transfusion-relevant S. aureus strains (TRSs) were subjected to comparative transcriptome analyses when grown in PCs vs. trypticase soy broth (TSB). Results of these analyses revealed differentially expressed genes involved in antibiotic resistance. Of interest, the norB gene (encodes for the NorB efflux pump, which is implicated in quinolone resistance and is negatively regulated by MgrA) was upregulated (1.2–4.7-fold increase) in all PC-grown TRS compared to TSB cultures. Minimal Bactericidal Concentration (MBC) of ciprofloxacin and norfloxacin in PC-grown TRS compared to TSB showed increased resistance to both quinolones in PC cultures. Complementary studies with non-transfusion-relevant strains S. aureus RN6390 and its norB and mgrA deletion mutants were conducted. MBC of ciprofloxacin and norfloxacin and RT-qPCR assays of these strains showed that not only norB, but also norA and norC may be involved in enhanced quinolone resistance in PC-grown S. aureus. The role of norB in S. aureus virulence was also tested using the silkworm Bombyx mori animal model; lethal dose 50 (LD50) assays revealed slightly higher virulence in larvae infected with the wild-type strain compared to the norB mutant. Conclusions: The PC storage environment enhances quinolone resistance in S. aureus and induces differential expression of efflux pump nor genes. Furthermore, our preliminary data of the involvement of NorB in virulence of S. aureus using a silkworm model merit further investigation with other systems such as a mammal animal model. Our results provide mechanistic insights to aid clinicians in the selection of antimicrobial treatment of patients receiving transfusions of S. aureus-contaminated PCs.


  • Phenazine-1 carboxylic acid of Pseudomonas aeruginosa induces the expression of Staphylococcus aureus Tet38 MDR efflux pump and mediates resistance to phenazines and antibiotics

    by Q C Truong-Bolduc, Y Wang, B G Lawton, H Brown Harding, L M Yonker, J M Vyas, D C Hooper

    In this study, we showed that phenazine-1 carboxylic acid (PCA) of Pseudomonas aeruginosa induced the expression of Tet38 efflux pump triggering Staphylococcus aureus resistance to tetracycline and phenazines. Exposure of S. aureus RN6390 to supernatants of P. aeruginosa PA14 and its pyocyanin (PYO)-deficient mutants showed that P. aeruginosa non-PYO phenazines could induce the expression of Tet38 efflux pump. Direct exposure of RN6390 to PCA compound at 0.25× MIC led to a five-fold increase in tet38 transcripts. Expression of Tet38 protein was identified through confocal microscopy using RN6390(pRN- tet38 p- yfp ) that expressed YFP under control of the tet38 promoter by PCA at 0.25× MIC. The MICs of PCA of a Tet38-overexpressor and a Δtet38 mutant showed a three-fold increase and a two-fold decrease, respectively, compared with that of wild-type. Pre-exposure of RN6390 to PCA (0.25× MIC) for 1 hour prior to addition of tetracycline (1× or 10× MIC) improved bacteria viability of 1.5-fold and 2.6-fold, respectively, but addition of NaCl 7% together with tetracycline at 10× MIC reduced the number of viable PCA-exposed RN6390 of a 2.0-log 10 CFU/mL. The transcript levels of tetR21 , a repressor of tet38 , decreased and increased two-fold in the presence of PCA and NaCl, respectively, suggesting that the effects of PCA and NaCl on tet38 production occurred through TetR21 expression. These data suggest that PCA-induced Tet38 protects S. aureus against tetracycline during coinfection with P. aeruginosa ; however, induced tet38 -mediated S. aureus resistance to tetracycline is reversed by NaCl 7%, a nebulized treatment used to enhance sputum mobilization in CF patients.


  • Blue Light Compromises Bacterial β‐Lactamases Activity to Overcome β‐Lactam Resistance

    by Carolina dos Anjos, Yin Wang, Que Chi Truong‐Bolduc, Paul K. Bolduc, Matthew Liu, David C. Hooper, R. Rox Anderson, Tianhong Dai, Leon G. Leanse

    Objective: In this study, we evaluated the effectiveness of antimicrobial blue light (aBL; 410 nm wavelength) against β‐lactamase‐carrying bacteria and the effect of aBL on the activity of β‐lactamases.Methods: Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae strains carrying β‐lactamases as well as a purified β‐lactamase enzymes were studied. β‐lactamase activity was assessed using a chromogenic cephalosporin hydrolysis assay. Additionally, we evaluated the role of porphyrins in the photoreaction, as well as protein degradation by sodium dodecyl‐sulfate polyacrylamide gel electrophoresis (SDS‐PAGE). Finally, we investigated the bactericidal effect of combined aBL‐ceftazidime exposure against a metallo‐β‐lactamase expressing P. aeruginosa strain.Results: Our study demonstrated that aBL effectively killed β‐lactamase‐producing bacteria and reduced β‐lactamase activity. After an aBL exposure of 1.52 J/cm2, a 50% reduction in enzymatic activity was observed in P. aeruginosa. Additionally, we found a 40% decrease in the photoreaction activity of porphyrins following an aBL exposure of 64.8 J/cm2. We also revealed that aBL reduced β‐lactamase activity via protein degradation (after 136.4 J/cm2). Additionally, aBL markedly improved the bactericidal effect of ceftazidime (by >4‐log10) in the metallo‐β‐lactamase P. aeruginosa strain.Conclusion: Our results provide evidence that aBL compromises bacterial β‐lactamase activity, offering a potential approach to overcome β‐lactam resistance in bacteria.


  • Staphylococcus aureus AbcA transporter enhances persister formation under β-lactam exposure

    by Q. C. Truong-Bolduc, Y. Wang, R. Ferrer-Espada, J. L. Reedy, A. T. Martens, Y. Goulev, J. Paulsson, J. M. Vyas, D. C. Hooper

    We evaluated the role of Staphylococcus aureus AbcA transporter in bacterial persistence and survival following exposure to the bactericidal agents nafcillin and oxacillin at both the population and single-cell levels. We show that AbcA overexpression resulted in resistance to nafcillin but not oxacillin. Using distinct fluorescent reporters of cell viability and AbcA expression, we found that over 6–14 hours of persistence formation, the proportion of AbcA reporter-expressing cells assessed by confocal microscopy increased sixfold as cell viability reporters decreased. Similarly, single-cell analysis in a high-throughput microfluidic system found a strong correspondence between antibiotic exposure and AbcA reporter expression. Persister cells grown in the absence of antibiotics showed neither an increase in nafcillin MIC nor in abcA transcript levels, indicating that survival was not associated with stable mutational resistance or abcA overexpression. Furthermore, persister cell levels on exposure to 1×MIC and 25×MIC of nafcillin decreased in an abcA knockout mutant. Survivors of nafcillin and oxacillin treatment overexpressed transporter AbcA, contributing to an enrichment of the number of persisters during treatment with pump-substrate nafcillin but not with pump-non-substrate oxacillin, indicating that efflux pump expression can contribute selectively to the survival of a persister population.


  • Open Access

    Editorial: Microbial interactions and survival mechanisms in chronic respiratory infections

    by Que Chi Truong-Bolduc, Chun-Hsing Liao, Hidemasa Nakaminami, Jacob Strahilevitz, Leon G. Leanse

  • NorA efflux pump mediates Staphylococcus aureus response to Pseudomonas aeruginosa pyocyanin toxicity

    by Q. C. Truong-Bolduc, L. M. Yonker, Y. Wang, B. G. Lawton, D. C. Hooper

    Endogenous transporters protect Staphylococcus aureus against antibiotics and also contribute to bacterial defense from environmental toxins. We evaluated the effect of overexpression of four efflux pumps, NorA, NorB, NorC, and Tet38, on S. aureus survival following exposure to pyocyanin (PYO) of Pseudomonas aeruginosa , using a well diffusion assay. We measured the PYO-created inhibition zone and found that only an overexpression of NorA reduced S. aureus susceptibility to pyocyanin killing. The MIC PYO of the NorA overexpressor increased threefold compared to that of wild-type RN6390 and was reduced 2.5-fold with reserpine, suggesting that increased NorA efflux caused PYO resistance. The PYO-created inhibition zone of a ΔnorA mutant was consistently larger than that of a plasmid-borne NorA overexpressor. PYO also produced a modest increase in norA expression (1.8-fold at 0.25 µg/mL PYO) that gradually decreased with increasing PYO concentrations. Well diffusion assays carried out using P. aeruginosa showed that ΔnorA mutant was less susceptible to killing by PYO-deficient mutants PA14 phzM and PA14 phzS than to killing by PA14. NorA overexpression led to reduced killing by all tested P. aeruginosa . We evaluated the NorA–PYO interaction using a collection of 22 clinical isolates from adult and pediatric cystic fibrosis (CF) patients, which included both S. aureus (CF-SA) and P. aeruginosa (CF-PA). We found that when isolated alone, CF-PA and CF-SA expressed varying levels of PYO and norA transcripts, but all four CF-PA/CF-SA pairs isolated concurrently from CF patients produced a low level of PYO and low norA transcript levels, respectively, suggesting a partial adaptation of the two bacteria in circumstances of persistent co-colonization.